Infectious Diseases Now

Scope & Guideline

Exploring the frontiers of infectious diseases.

Introduction

Welcome to your portal for understanding Infectious Diseases Now, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageMulti-Language
ISSN2666-9927
PublisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2021 to 2024
AbbreviationINFECT DIS NOW / Infect. Dis. Now
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE

Aims and Scopes

Infectious Diseases Now focuses on advancing the understanding, prevention, and treatment of infectious diseases through high-quality research. The journal encompasses a broad spectrum of topics related to infectious diseases, emphasizing both clinical and public health perspectives.
  1. Clinical Management of Infectious Diseases:
    The journal publishes studies on the clinical management of infectious diseases, including treatment protocols, antibiotic stewardship, and vaccination strategies, aiming to improve patient outcomes.
  2. Epidemiology and Surveillance:
    Research related to the epidemiology of infectious diseases, including surveillance of outbreaks and patterns of disease transmission, provides insights into public health challenges.
  3. Antimicrobial Resistance:
    The journal emphasizes the growing threat of antimicrobial resistance, presenting studies that explore resistance patterns, risk factors, and strategies for effective management.
  4. Global Health Perspectives:
    Infectious Diseases Now includes research addressing global health issues, particularly in low- and middle-income countries, highlighting the international implications of infectious diseases.
  5. Innovative Research Methodologies:
    The journal encourages the use of innovative methodologies in infectious disease research, including machine learning, genomic studies, and novel diagnostic techniques.
Infectious Diseases Now is increasingly focusing on contemporary challenges and emerging themes in infectious diseases, reflecting the dynamic nature of the field.
  1. Impact of COVID-19 on Healthcare Systems:
    The journal has seen a surge in studies exploring the impact of COVID-19 on healthcare systems, responses to the pandemic, and long-term effects on public health.
  2. Telemedicine and Remote Healthcare:
    Research on telemedicine and remote healthcare delivery has gained prominence, particularly in the context of managing infectious diseases during and after the pandemic.
  3. Mental Health Impacts of Infectious Diseases:
    Emerging studies addressing the mental health implications of infectious diseases, especially in the context of COVID-19, are becoming increasingly relevant.
  4. Zoonotic Diseases and One Health Approach:
    There is a growing emphasis on zoonotic diseases and the One Health approach, highlighting the interconnectedness of human, animal, and environmental health.
  5. Vaccine Development and Innovation:
    The journal is increasingly publishing research on innovative vaccine development strategies, particularly mRNA technology and its applications beyond COVID-19.

Declining or Waning

While Infectious Diseases Now covers a wide range of topics, some areas have shown a decline in publication frequency, reflecting shifting priorities and emerging challenges in the field.
  1. Traditional Vaccination Strategies:
    There has been a noticeable decrease in studies focusing solely on traditional vaccination strategies, as newer approaches and technologies are increasingly prioritized.
  2. Non-communicable Disease Interactions:
    Research that intersects infectious diseases with non-communicable diseases appears to be waning, possibly overshadowed by urgent infectious disease concerns like COVID-19.
  3. Invasive Procedures and Associated Infections:
    Papers specifically addressing infections associated with invasive procedures have seen a decline, as the focus shifts more towards preventive measures and outpatient management.
  4. Localized Infectious Disease Case Studies:
    While case studies remain important, there is a trend towards broader epidemiological studies rather than localized case reports, reflecting a shift in research focus.
  5. Historical Perspectives on Infectious Diseases:
    Research that focuses on historical perspectives or retrospective analyses of infectious diseases is declining, as the journal emphasizes contemporary issues and future directions.

Similar Journals

EPIDEMIOLOGY AND INFECTION

Pioneering Insights for Infectious Disease Management
Publisher: CAMBRIDGE UNIV PRESSISSN: 0950-2688Frequency: 1 issue/year

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

LANCET INFECTIOUS DISEASES

Unraveling Complexities in Infectious Disease Science
Publisher: ELSEVIER SCI LTDISSN: 1473-3099Frequency: 12 issues/year

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Fostering innovation in the understanding of infectious agents.
Publisher: EDICIONES DOYMA S AISSN: 0213-005XFrequency: 10 issues/year

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

CLINICAL MICROBIOLOGY AND INFECTION

Pioneering Research in Infectious Diseases
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

Infectious Diseases and Clinical Microbiology

Bridging research and clinical practice in infectious health.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

Infectious Diseases

Innovative Research for a Healthier Tomorrow
Publisher: TAYLOR & FRANCIS LTDISSN: 2374-4235Frequency: 12 issues/year

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

CLINICAL INFECTIOUS DISEASES

Uncovering breakthroughs in diagnosis and treatment.
Publisher: OXFORD UNIV PRESS INCISSN: 1058-4838Frequency: 24 issues/year

Clinical Infectious Diseases, published by Oxford University Press Inc, is a premier journal in the fields of infectious diseases and microbiology, distinguished by its esteemed Q1 ranking in both categories as of 2023. Since its inception, the journal has served as a vital platform for disseminating cutting-edge research and significant advancements in the diagnosis, treatment, and prevention of infectious diseases. With a broad scope encompassing clinical trials, epidemiological studies, and public health research, it targets a diverse readership, including researchers, healthcare professionals, and students. The journal's robust reputation is underscored by its impactful contributions to scientific understanding, making it a critical resource for those striving to combat infectious diseases globally. Clinical Infectious Diseases is not open access but offers various subscription options, ensuring comprehensive access to its high-quality content. With a historical continuity from 1985 to present, the journal remains at the forefront of medical research, paving the way for future innovations in the field.

Current Infectious Disease Reports

Advancing the Frontiers of Infectious Disease Knowledge
Publisher: SPRINGERISSN: 1523-3847Frequency: 12 issues/year

Current Infectious Disease Reports, published by SPRINGER, is a leading journal dedicated to advancing knowledge in the field of infectious diseases. With an ISSN of 1523-3847 and an E-ISSN of 1534-3146, this peer-reviewed journal has established itself as a vital resource for researchers and healthcare professionals since its inception in 1999. The journal's impact in the academic community is underscored by its Q1 ranking in Infectious Diseases for 2023, placing it in the top quartile of influential journals in the field. Furthermore, it holds a respectable position at rank #95 out of 344 in the Scopus database, reflecting its substantial contribution to medicine and public health. While currently not an open access journal, it offers a wealth of articles covering the latest research, case studies, and reviews, making it an indispensable tool for those aiming to stay at the forefront of infectious disease science. As we navigate an era marked by emerging and re-emerging infectious threats, Current Infectious Disease Reports remains committed to providing high-quality, relevant research that supports evidence-based practice and informs future studies globally.

Open Forum Infectious Diseases

Fostering collaboration in the fight against infectious diseases.
Publisher: OXFORD UNIV PRESS INCISSN: 2328-8957Frequency: 12 issues/year

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

Infectious Diseases and Therapy

Elevating research to combat infectious diseases worldwide.
Publisher: SPRINGER LONDON LTDISSN: 2193-8229Frequency: 4 issues/year

Infectious Diseases and Therapy is a premier scholarly journal published by Springer London Ltd, dedicated to advancing the understanding of infectious diseases through rigorous research and evidence-based therapy. With an esteemed Q1 ranking in both the Infectious Diseases and Microbiology (medical) categories, this journal is a vital resource for researchers, healthcare professionals, and students aiming to stay at the forefront of developments within the field. Launched in 2012, it has embraced an Open Access model, ensuring that groundbreaking studies and critical reviews are accessible to a global audience. Operating from its office in London, the journal encourages the dissemination of innovative therapies and diagnostic methods, fostering collaboration and knowledge sharing among the scientific community. In a landscape where infectious diseases pose significant health challenges, Infectious Diseases and Therapy stands as an essential platform for impactful research that can lead to improved healthcare outcomes worldwide.